Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The pattern recognition receptor (PRR) system comprises a diverse group of germline-encoded receptors that detect conserved microbial structures known as pathogen-associated molecular patterns (PAMPs) (Janeway & Medzhitov, 2002). These receptors, including Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs), are essential for initiating the innate immune response and shaping subsequent adaptive immunity (Kawasaki & Kawai, 2014). PRRs are expressed on various cells, including macrophages, dendritic cells, and epithelial cells, where they monitor the extracellular and intracellular environments for signs of invasion (Mogensen, 2009). In disease contexts, PRR signaling is critical for the defense against bacterial, viral, and fungal infections, but its overactivation can lead to systemic inflammatory response syndrome or chronic autoimmune conditions (Takeuchi & Akira, 2010). Therapeutically, PRR agonists are utilized as vaccine adjuvants to enhance immunogenicity and as monotherapies in oncology to stimulate the tumor microenvironment (Kaczanowska et al., 2013). For example, Imiquimod targets TLR7 to treat skin cancers, while Monophosphoryl lipid A is a TLR4 agonist used in vaccine formulations (Borden, 2020). Because this entry represents a broad biological mechanism involving multiple receptor families rather than a single protein, it does not constitute a discrete molecular target in the traditional sense (Kumar et al., 2011).
Activation of various pattern recognition receptors (PRRs) by pathogen-associated molecular patterns (PAMPs) to stimulate innate and adaptive immune responses.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pattern recognition receptor system (PRR system).